
Tamarah Aldawoodi, MBChB
Department of General Oncology, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
2012 | University of Al-Nahrain, College of Medicine, Baghdad, IQ, M.B.Ch.B degree |
Postgraduate Training
2021-2024 | Postgraduate Fellow, Hematology and Medical Oncology, The University of Texas Health Science Center of San Antonio, San Antonio, Texas |
2018-2020 | Resident, Internal Medicine Residency PGY-2, 3, The University of Chicago (Northshore), Evanston, Illinois |
2017-2018 | Resident, Internal Medicine Residency PGY-1, University of Nevada School of Medicine, Las Vegas, Nevada |
Honors & Awards
“Honor” degree, Ministry of higher education in Baghdad, Iraq | |
Honored at Alkadhimya Teaching Hospital, Alkadhimya Teaching Hospital | |
American College of Physicians Resident of the Year Award, University of Chicago (NorthShore) Internal Medicine Residency Program at the Northern Illinois Region Conference | |
Texas Society of Clinical Oncology Poster Winning Award, Texas Society of Clinical Oncology |
Selected Publications
Other Articles
- Aldawoodi T Real-world data: Clinical characteristics and outcomes of patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab in Veteran Health Administration. None None(None):None, 2024. PMID: None.
- Azab M, Shah S, Liu X,, Shafi A, Tamarah Al Dawoodi, Caroline Liu, Hyun Phil Shin, Ji Won Yoo Necessity of interrupted time series analysis in evaluating the impact of PHS risk identification and introduction of direct acting antiviral therapy and share 35 implementation. None None(1):None, 2018. PMID: None.
- Munaf AL-Kadhimi, Fernanda Wah, Aldawoodi T, Julio Peguero, Luis T Campos Autoimmune hemolytic anemia presenting concurrently with thrombotic thrombocytopenic purpura. International Journal of Case Reports and Images 2016 None(None):None, 2016. PMID: None.
- Munaf AL-Kadhimi, Tamarah AL-Dawoodi, Julio Peguero, Luis T. Campos Syringoid eccrine carcinoma: A case report. Journal of Case Reports and Images in Oncology None(None):None. PMID: None.
- Aldawoodi T •Patient-Centered, AI-Enabled, Molecular-Informed Data Fabric for Clinical Treatment Decision Support. Enabled, Molecular-Informed Data Fabric for Clinical Treatment Decision Support - AI in Precision Oncology None(None):127-144. PMID: None.
- AL-Kadhimi M, Al-Dawoodi T, Peguero J, Campos LT Liquid Biopsy in Advanced Gastric Malignancy and Molecular Targeted Therapy. Oncology Consultants 3(2 Journal of Cancer Science and Clinical Oncology):None. PMID: None.
- Mohamed Azab, Syed Shah, Xibei Liu, Johnson Ukken, Mary Froehlich, Amaan Shafi, Tamarah Al Dawoodi, Caroline Liu, Hyun Phil Shin, Ji Won Yoo Extended DAA indications of hepatitis C patients awaiting liver transplantation and further statistical consideration. A letter to the Editor None(None):None. PMID: None.
Book Chapters
- Aldawoodi T, Azab M, Vogelzang NJ. Mesothelioma. In: McGraw Hill Education. None. McGraw Hill Education, None, 2022.
Selected Presentations & Talks
Local Presentations
- 2023. Predictive Biomarkers of Response to Chemotherapy in Breast Cancer. None. Grand Rounds of Hematology/Oncology at UT Health Houston. Houston, Texas, US.
Regional Presentations
- 2023. Meta-Analysis of Clinical Characteristics and Outcomes in Breast Cancer Patients with Visceral Crisis. None. San Antonio Breast Cancer Symposium. San Antonio, Texas, US.
- 2023. Real-world data: Clinical characteristics and outcomes of patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab in Veteran Health Administration. None. Texas Society of Clinical Oncology, US.
- 2023. T Cell Histiocyte Rich Non-Hodgkin Lymphoma case presentation and discussion. None. MD Anderson Statewide Grand rounds. San Antonio, Texas, US.
- 2022. COVID-19 lockdown resulting in advanced cancer and worse histology at presentation in Hispanics. None. San Antonio Breast Cancer Symposium. San Antonio, Texas, US.
- 2022. Access to medical coverage in newly diagnosed breast cancer patients a minority population during COVID-19 pandemic. None. San Antonio Breast Cancer Symposium. San Antonio, Texas, US.
- Disparities in adverse events between Hispanics and non-Hispanics Whites enrolled in early-phase clinical trials. None. UTHSCSA Long School of Medicine Research Symposium. San Antonio, Texas, US.
National Presentations
- 2024. Determining the role of septic expression in response of breast cancer patients to microtubule targeted chemotherapy. None. AACR. San Diego, California, US.
- 2023. Treatment patterns post atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: Real-world analysis at Veterans Health Administration comparing lenvatinib vs. sorafenib. None. Online Poster ASCO 2023. Chicago, Illinois, US.
- 2022. Exposure to Bisphosphonates and Risk of Breast Cancer: A Meta-analysis of Published Observational Studies. None. Society of General Internal Medicine National Meeting. Philadelphia, Pennsylvania, US.
- 2018. 1-year Mortality Outcome of Nocturnal Positive Pressure Noninvasive Ventilation and Oxygen Therapy versus Conventional Long-term Oxygen Therapy (LTOT) in Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Patients. None. American Thoracic Society Annual Meeting. San Diego, California, US.
- 2018. Germline T790M mutation of the epidermal growth factor receptor (EGFR) in a case of multifocal adenocarcinoma of the lung without exposure to Tyrosine Kinase Inhibitors (TKI). None. American Thoracic Society Annual Meeting. San Diego, California, US.
- 2018. Exposure to Bisphosphonates and Risk of Breast Cancer: A Meta-analysis of Published Observational Studies. None. Society of General Internal Medicine National Meeting, Colorado, US.
- 2018. Exposure to Bisphosphonates and Risk of Breast Cancer: A Meta-analysis of Published Observational Studies. None. 35th Annual Miami Breast Cancer Conference. Miami, Florida, US.
- 2017. Germline T790M mutation of the epidermal growth factor receptor (EGFR) in a case of multifocal adenocarcinoma of the lung without exposure to Tyrosine Kinase Inhibitors (TKI): A Case Report. None. American College of Physicians Regional Meeting. Las Vegas, Nevada, US.
- The Long-Term False Negative Rate of Pulmonary Nodule Biopsies: A Retrospective Analysis of Patients Treated at a Single Institution. None. OncLiv Fellows. Chicago, Illinois, US.
Patient Reviews
CV information above last modified November 14, 2024